These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4764146)

  • 21. The clinical need for new antiviral drugs directed against influenza virus.
    McCullers JA
    J Infect Dis; 2006 Mar; 193(6):751-3. PubMed ID: 16479505
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
    Takashita E; Ejima M; Ogawa R; Fujisaki S; Neumann G; Furuta Y; Kawaoka Y; Tashiro M; Odagiri T
    Antiviral Res; 2016 Aug; 132():170-7. PubMed ID: 27321665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.
    Streeter DG; Witkowski JT; Khare GP; Sidwell RW; Bauer RJ; Robins RK; Simon LN
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1174-8. PubMed ID: 4197928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy of influenza.
    Eşanu V
    Virologie; 1982; 33(4):283-302. PubMed ID: 6761956
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-influenza virus agent].
    Nakamura S; Kohno S
    Nihon Rinsho; 2012 Apr; 70(4):568-73. PubMed ID: 22568136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influenza becomes treatable. Breakthrough against the last great epidemic?].
    Einecke D
    MMW Fortschr Med; 1999 Dec; 141(49-50):4-6. PubMed ID: 10726138
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.
    Browne MJ; Moss MY; Boyd MR
    Antimicrob Agents Chemother; 1983 Mar; 23(3):503-5. PubMed ID: 6847176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus.
    Togo Y; McCracken EA
    J Infect Dis; 1976 Jun; 133 Suppl():A109-13. PubMed ID: 778306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapeutic control of influenza.
    Stephenson I; Nicholson KG
    J Antimicrob Chemother; 1999 Jul; 44(1):6-10. PubMed ID: 10459804
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of test methods in influenza chemotherapy.
    Tisdale M; Bauer DJ
    J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):55-62. PubMed ID: 1206032
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the antiviral activity of 1-adamantanamine.
    Tyrrell DA; Bynoe ML; Hoorn B
    Br J Exp Pathol; 1965 Aug; 46(4):370-5. PubMed ID: 5317962
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the in vivo antiviral effects of benzothiazole derivatives against various influenza A2 strains.
    Akerfeldt S
    J Med Chem; 1970 Sep; 13(5):1012-3. PubMed ID: 5458344
    [No Abstract]   [Full Text] [Related]  

  • 35. Quo vadis antiviral agents for herpes, influenza and HIV?
    Oxford JS
    J Med Microbiol; 1995 Jul; 43(1):1-3. PubMed ID: 7608949
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug resistance and influenza pandemics.
    Stilianakis NI; Perelson AS; Hayden FG
    Lancet; 2002 May; 359(9320):1862-3. PubMed ID: 12044407
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral treatment of influenza in South Korea.
    Choe YJ; Lee H; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):741-9. PubMed ID: 25835433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Targeted drugs against influenza--how will this affect the epidemics?].
    Pyhälä R; Ziegler T; Lumio J
    Duodecim; 2000; 116(1):13-5. PubMed ID: 11764456
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiviral Medications, Part 1: Treating Herpes and Influenza Viruses.
    Rhea Faye D FR; Kathryn P; Donna G
    Medsurg Nurs; 2017 Jan; 26(1):47-52. PubMed ID: 30351575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 1-beta-D-ribofuranosyl 1, 2, 4-triazole-3-carboxamide on influenza virus replication and polypeptide synthesis.
    Oxford JS
    J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):71-6. PubMed ID: 1239442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.